GANGAPHARM
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Ganga Pharmaceuticals To Consider Fund Raising
Nov 27 (Reuters) - Ganga Pharmaceuticals Ltd GNPH.BO:
TO CONSIDER FUND RAISING
Source text for Eikon: ID:nBSE1s1dpg
Further company coverage: GNPH.BO
(([email protected];))
Nov 27 (Reuters) - Ganga Pharmaceuticals Ltd GNPH.BO:
TO CONSIDER FUND RAISING
Source text for Eikon: ID:nBSE1s1dpg
Further company coverage: GNPH.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Ganga Pharma. do?
Ganga Pharmaceuticals Ltd. is a pharmaceutical company specializing in the manufacturing of ayurvedic products including tablets, pills, balms, creams, syrups, and oils.
Who are the competitors of Ganga Pharma.?
Ganga Pharma. major competitors are Kobo Biotech, Zyden Gentec, Fabino Enterprises, MPS Pharmaa, Secunderabad Health., Hemo Organic, Senbo Industries. Market Cap of Ganga Pharma. is ₹6 Crs. While the median market cap of its peers are ₹5 Crs.
Is Ganga Pharma. financially stable compared to its competitors?
Ganga Pharma. seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Ganga Pharma. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ganga Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ganga Pharma. allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Ganga Pharma. balance sheet?
Balance sheet of Ganga Pharma. is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Ganga Pharma. improving?
The profit is oscillating. The profit of Ganga Pharma. is ₹0.05 Crs for Mar 2024, ₹0.04 Crs for Mar 2023 and ₹0.04 Crs for Mar 2022
Is the debt of Ganga Pharma. increasing or decreasing?
The net debt of Ganga Pharma. is decreasing. Latest net debt of Ganga Pharma. is ₹1.12 Crs as of Mar-25. This is less than Mar-24 when it was ₹1.32 Crs.
Is Ganga Pharma. stock expensive?
Ganga Pharma. is not expensive. Latest PE of Ganga Pharma. is 82.59, while 3 year average PE is 187. Also latest EV/EBITDA of Ganga Pharma. is 0 while 3yr average is 19.4.
Has the share price of Ganga Pharma. grown faster than its competition?
Ganga Pharma. has given lower returns compared to its competitors. Ganga Pharma. has grown at ~9.57% over the last 3yrs while peers have grown at a median rate of 14.65%
Is the promoter bullish about Ganga Pharma.?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Ganga Pharma. is 56.02% and last quarter promoter holding is 56.02%.
Are mutual funds buying/selling Ganga Pharma.?
There is Insufficient data to gauge this.